Riskpilot← Back to searchSign inGet full accessHaninge Naprapat AB
ABActiveOrg 5565125332Handens Stationsväg 27Physiotherapy activities · NACE 8695Est. 19955-9 employees
Revenue 2024
SEK 3,2M
+7% vs 2023
EBITDA margin
5.1%
+422% vs 2023
Equity ratio
43.3%
Financial strength
Net profit 2024
SEK 126K
+213% vs 2023
| Revenue | SEK 3,2M | +7% |
| EBITDA | SEK 164K | +422% |
| Net profit | SEK 126K | +213% |
| Total assets | SEK 525K | -3% |
| Equity | SEK 227K | +25% |
| Employees | — | — |
Legal name
Haninge Naprapat AB
Org number
5565125332
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
18 maj 1995
Share capital
SEK 100 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva naprapatverksamhet, konsultation inom friskvård, äga och förvalta fast egendom samt därmed förenlig verksamhet.
Address
Handens Stationsväg 27
Phone
+4687157555
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 101 | 2 899 | 3 071 | 2 985 | 3 191 |
| Staff expenses | — | — | −2 522 | −2 525 | −2 470 |
| EBITDA | 476 | 492 | 20 | −51 | 164 |
| Depreciation & amort. | −34 | −64 | −64 | −63 | −37 |
| EBIT | 442 | 428 | −45 | −114 | 127 |
| Net financials | — | — | 0 | 2 | −3 |
| Profit before tax | 342 | 428 | 55 | −112 | 124 |
| Tax | −73 | −88 | −23 | — | 2 |
| Net profit | 269 | 340 | 33 | −112 | 126 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 191 | 1 239 | 732 | 540 | 525 |
| Equity | 470 | 810 | 493 | 181 | 227 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 621 | 328 | 240 | 359 | 298 |
| Total debt | 621 | 328 | 240 | 359 | 298 |
EBITDA margin
5.1%
This company
15.8%
Market median
-68% vs market
20202024
Equity ratio
43.3%
This company
38.2%
Market median
+13% vs market
20202024
Return on equity
55.5%
This company
18.4%
Market median
+202% vs market
20202024
Net profit margin
4.0%
This company
8.1%
Market median
-51% vs market
20202024
Asset turnover
6.08×
This company
1.12×
Market median
+443% vs market
20202024
Debt / equity
1.31×
This company
0.62×
Market median
-111% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KA Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Haninge Naprapat AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl Anders Michael Palm | Chief Executive Officer | 0 companies |
| Jennifer Kate Palm | Deputy Board Member | 0 companies |